COLOUR BLINDNESS ACQUIRED

This adverse event was reported 363 times

These drugs are most commonly taken by patients reporting COLOUR BLINDNESS ACQUIRED:

# Drug Count
0 PREGABALIN 34
1 NATALIZUMAB 21
2 VORICONAZOLE 15
3 ADALIMUMAB 14
4 PREDNISONE 14
5 SILDENAFIL CITRATE 13
6 TADALAFIL 13
7 FINGOLIMOD HCL 12
8 INTERFERON BETA-1A 12
9 RANIBIZUMAB 12
See all common drugs associated with COLOUR BLINDNESS ACQUIRED

COLOUR BLINDNESS ACQUIRED is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 TETRACAINE 1 0.0025
1 TEDIZOLID PHOSPHATE 2 0.0025
2 CEFUROXIME AXETIL 8 0.0023
3 SIBEPRENLIMAB 1 0.0015
4 DISOPYRAMIDE PHOSPHATE 1 0.0012
5 BINIMETINIB 8 0.0010
6 NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND DEXAMETHASONE 1 0.0009
7 ENCORAFENIB 8 0.0008
8 SENNA LAXATIVE 1 0.0008
9 BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE 1 0.0006
See all drugs enriched for association with COLOUR BLINDNESS ACQUIRED